Audrey Billhymer

Audrey Billhymer

Auto-generated profile, based on publicly available information

Audrey Billhymer

Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois Urbana-Champaign, Urbana, IL

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2026 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
JRJennifer M Reinhart
Jennifer M Reinhart
FLFlorence Leduc
Florence Leduc
AHAndrew S. Hanzlicek
Andrew S. Hanzlicek
TMTodd Marlo
Todd Marlo
ABAudrey Billhymer
Audrey Billhymer
LFLauralei L Fisher-Cronkhite
Lauralei L Fisher-Cronkhite
Background: Itraconazole is a widely used treatment for blastomycosis in dogs but serum drug concentrations vary widely between individuals. Hypothesis/Objectives: Establish a protocol for therapeutic drug monitoring of itraconazole in dogs with blastomycosis. Animals: Fourteen dogs with blastomycosis. Methods: Single-arm, prospective study. The initial dosage of itraconazole was 5 mg/kg/day. Therapeutic drug monitoring was performed after 2 weeks and then monthly until clinical and antigenic remission. Itraconazole dosages were adjusted to maintain trough serum concentrations within the target range (2-7 μg/mL) using a standardized equation. Results: Twelve of 14 dogs required at least 1 dosage adjustment and 9 dogs required additional adjustments even after target concentrations were initially achieved. Dosage changes tended to occur at sequential visits, often consisting of a dosage increase followed by a dosage decrease at the next visit, or vice versa. No correlation was found between itraconazole dosage and serum concentration (r = 0.080, P = .43). Dogs were treated for a median of 7.9 months (range, 2.6-9.9). Median itraconazole dosage at disease remission (2.8 mg/kg/day; range, 0.9-5.0) was significantly lower than the initial dosage (4.9 mg/kg/day; range, 4.0-5.4; P < .001). All dogs successfully achieved remission of blastomycosis and only one occurrence of antigenic relapse occurred. Conclusions and clinical importance: Most dogs with blastomycosis require dosage adjustments to maintain itraconazole concentrations in the target range. Repeat serum drug concentrations should be measured after dosage adjustments to ensure target concentrations are reached. Although 5 mg/kg/day is an appropriate initial dosage, the itraconazole dosage needed to maintain target serum concentrations appears to decrease over time.

1 March 2026 in American Journal of Veterinary Research
Verified
Journal Article
Open access
AFAmanda Finn
Amanda Finn
ASAmy N. Schnelle
Amy N. Schnelle
ABAudrey Billhymer
Audrey Billhymer
JRJennifer M. Reinhart
Jennifer M. Reinhart
Objective: To describe the clinical, cytologic, and radiographic features of inflammatory arthritis associated with blastomycosis in dogs. Methods: This study included 12 dogs with blastomycosis and cytologic evidence of inflammation in at least 1 joint identified at a tertiary referral center over a 25-year period. Median age of presentation was 5.0 (1.1 to 9.0) years, and 4 of 12 cases were Labrador Retrievers. Musculoskeletal signs were the primary complaint for 10 dogs, while the other 2 presented for respiratory concerns. All dogs were lame upon evaluation, and 10 of 12 had palpable joint swelling. All dogs had evidence of blastomycosis in at least 1 other body system. Results: Of 25 joint fluid cytologies, interpretations consisted of inflammatory arthritis in 21 joints (12 dogs), degenerative joint disease in 1 joint (1 dog), and unremarkable in 3 joints (2 dogs). The inflammation was categorized as suppurative (17 joints, 11 dogs) or pyogranulomatous (4 joints, 1 dog). Intra-articular Blastomyces organisms were observed in 10 joints (6 dogs). Eight of 9 joints (7 of 8 dogs) imaged had at least 1 radiographic abnormality, including 5 joints with osteolytic lesions. All bony lesions were periarticular. Ten dogs received oral antifungal drugs. Three dogs died within 1 month of evaluation; all 6 dogs with long-term follow-up achieved blastomycosis remission, but 2 required surgical arthrodesis of affected joints. Conclusions: Not all dogs with blastomycosis-associated arthritis have cytologically detectable organisms in their joint fluid. Clinical Relevance: Unlike other sampling sites where pyogranulomatous inflammation predominates, suppurative inflammation is most common in the joints.